Peregrine Gets FDA OK For Cotara Phase III, Awaits Partner

Feb. 25, 2003

By Brady Huggett

Peregrine Gets FDA OK For Cotara Phase III, Awaits Partner

Feb. 25, 2003

By Brady Huggett

BioMarin Raises $75M Publicly, Gets Good News On Aldurazyme

Feb. 24, 2003

By Brady Huggett

BioMarin Raises $75M Publicly, Gets Good News On Aldurazyme

Feb. 24, 2003

By Brady Huggett

Biogen's Amevive Shot Down In Europe; Approval Years Away

Feb. 21, 2003

By Brady Huggett

SomaLogic Raises $19.5M To Develop Proteomics Products

Feb. 21, 2003

By Brady Huggett

Biogen's Amevive Shot Down In Europe; Approval Years Away

Feb. 21, 2003

By Brady Huggett

SomaLogic Raises $19.5M To Develop Proteomics Products

Feb. 21, 2003

By Brady Huggett

BattellePharma Raises $22M To Develop Inhalation Program

Feb. 20, 2003

By Brady Huggett

BattellePharma Raises $22M To Develop Inhalation Program

Feb. 20, 2003

By Brady Huggett